BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 8756217)

  • 41. [Methods and monitoring of antibiotic therapy of infectious endocarditis].
    Besnier JM; Choutet P
    Rev Prat; 1998 Mar; 48(5):513-8. PubMed ID: 9781114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bacterial endocarditis. Comments on 54 cases].
    Dimitriu SM; Ulianov M; Luca V; Vâţă A; Turcu T; Scurtu C; Mihalache D; Cercel I; Apostol A; Hurmuzache T
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(4):587-95. PubMed ID: 3835652
    [No Abstract]   [Full Text] [Related]  

  • 43. [Surgical treatment of infective endocarditis].
    Takaba T; Funami M; Yamada M; Mushiaki T; Kadokura M; Ishii J; Yamashiro M; Miya T; Morimoto K
    Kyobu Geka; 1984 Sep; 37(10):749-56. PubMed ID: 6503072
    [No Abstract]   [Full Text] [Related]  

  • 44. Infective endocarditis: update 1996.
    Pelletier LL
    Compr Ther; 1996 Aug; 22(8):471-6. PubMed ID: 8879913
    [No Abstract]   [Full Text] [Related]  

  • 45. Infectious endocarditis in maintenance hemodialysis patients. A report of four episodes among three patients.
    Ribot S; Rothfeld D; Frankel HJ
    Am J Med Sci; 1972 Sep; 264(3):183-8. PubMed ID: 4648220
    [No Abstract]   [Full Text] [Related]  

  • 46. [Endocarditis caused by group B streptococci in adults].
    Marron A; Carratalà J; Peña C; Rosón B; Tubau F; Rufí G
    Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):147-50. PubMed ID: 9235055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of patients requiring valve surgery during active infective endocarditis.
    Hill EE; Herregods MC; Vanderschueren S; Claus P; Peetermans WE; Herijgers P
    Ann Thorac Surg; 2008 May; 85(5):1564-9. PubMed ID: 18442538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Infectious endocarditis: clinical findings, therapy and course in 103 patients].
    Lode H; Harnoss CM; Wagner J; Biamino G; Schröder R
    Dtsch Med Wochenschr; 1982 Jun; 107(25):967-74. PubMed ID: 7084062
    [No Abstract]   [Full Text] [Related]  

  • 49. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
    Woods CW; Cheng AC; Fowler VG; Moorefield M; Frederick J; Sakoulas G; Meka VG; Tenover FC; Zwadyk P; Wilson KH
    Clin Infect Dis; 2004 Apr; 38(8):1188-91. PubMed ID: 15095227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infective endocarditis: a frequent disease in dialysis patients.
    Hoen B
    Nephrol Dial Transplant; 2004 Jun; 19(6):1360-2. PubMed ID: 15004259
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Corne P; Marchandin H; Macia JC; Jonquet O
    Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
    Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
    Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infective endocarditis.
    Agarwal AK
    Compr Ther; 1985 Mar; 11(3):17-25. PubMed ID: 3979023
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of antibiotic therapy following valve replacement for native valve endocarditis.
    Fadel HJ; Tleyjeh IM; Steckelberg JM; Wilson WR; Baddour LM
    Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1395-8. PubMed ID: 19705174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Infective endocarditis: epidemiology and diagnosis].
    Hoen B
    Rev Med Interne; 2007 Jun; 28 Suppl 1():S22-6. PubMed ID: 17462793
    [No Abstract]   [Full Text] [Related]  

  • 57. Anti-infective therapy of infectious endocarditis.
    Cleary TG; Kohl S
    Pediatr Clin North Am; 1983 Apr; 30(2):349-64. PubMed ID: 6856372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Galani L; Pefanis A; Sakka V; Iliopoulos D; Donta I; Triantafyllidi H; Skiadas I; Karayiannakos P; Giamarellou H
    Int J Antimicrob Agents; 2009 Jan; 33(1):65-9. PubMed ID: 18818055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: Cure with prolonged/high-dose daptomycin without toxicity.
    Cunha BA; Eisenstein LE; Hamid NS
    Heart Lung; 2006; 35(3):207-11. PubMed ID: 16701116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.